Zhao, Yan
Wang, Lee-kai
Eskin, Ascia
Kang, Xuedong
Fajardo, Viviana M.
Mehta, Zubin
Pineles, Stacy
Schmidt, Ryan J.
Nagiel, Aaron
Satou, Gary
Garg, Meena
Federman, Myke
Reardon, Leigh C.
Lee, Steven L.
Biniwale, Reshma
Grody, Wayne W.
Halnon, Nancy
Khanlou, Negar
Quintero-Rivera, Fabiola
Alejos, Juan C.
Nakano, Atsushi
Fishbein, Gregory A.
Van Arsdell, Glen S.
Nelson, Stanley F.
Touma, Marlin http://orcid.org/0000-0002-2827-4068
Funding for this research was provided by:
American Heart Association (18CDA34110414)
U.S. Department of Defense (W81XWH-18-1-0164)
NIH/NHLBI (1R01 HL153853-01)
Article History
Received: 1 December 2020
Revised: 28 June 2021
Accepted: 5 July 2021
First Online: 13 August 2021
Declarations
:
: All human studies were conducted in accordance with the regulation of the University of California Los Angeles Institutional Review Board (IRB). All subjects provided written informed consent to participate in this study. Electronic medical records, 3-generation family pedigree, and specimen collection were acquired through the UCLA Congenital Heart Defect (CHD) BioCore following the UCLA-IRB-approved protocols. All specimens were de-identified following acquisition.
: Informed consent for participation in research study, reporting, and publication was obtained for all subjects upon enrollment according to the UCLA-IRB-approved protocol.
: The authors declare no competing interests.